Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs

1st October 2005
Centers for Disease Control and Prevention - Federal Government Agency [U.S.]
Summary,

| More

DISEASE/CONDITION(S)
Cystic fibrosis

GUIDELINE CATEGORY
Counseling
Diagnosis
Screening

CLINICAL SPECIALTY
Family Practice
Gastroenterology
Infectious Diseases
Nutrition
Obstetrics and Gynecology
Pediatrics
Pulmonary Medicine

INTENDED USERS
Health Care Providers
Hospitals
Physicians
Public Health Departments

GUIDELINE OBJECTIVE(S) To review and evaluate the scientific evidence on benefits and risks of newborn screening for cystic fibrosis (CF)
To review screening, diagnostics, and follow-up concerns in CF newborn screening decision making
To disseminate information about models and best practices for states that choose to adopt newborn screening for CF
To advise states that choose to adopt newborn screening for CF on how to maximize benefits and minimize harms in implementing screening

TARGET POPULATION
Newborn infants
Copyright® 2004 - 2010 Business Briefings, Ltd. All rights reserved.
Touch Respiratory is for informational purposes and should not be considered medical advice, diagnosis or treatement recommendations.